ADMP News and Press, Adamis Pharmaceuticals Corporation From 03/16/23

SAN DIEGO, March 16, 2023 (GLOBE NEWSWIRE) -- Adamis Pharmaceuticals Corporation (NASDAQ: ADMP), a biopharmaceutical company focused on developing and commercializing products in various therapeutic areas, including opioid overdose, allergy, respiratory and inflammatory disease, today announc...

2023-03-14 08:38:09 ET Adamis Pharmaceuticals ( NASDAQ: ADMP ) shares fell 5% premarket on Tuesday after the biopharmaceutical company launched a securities offering to raise $3M in gross proceeds. The firm entered into a securities purchase agreement with a single ins...

SAN DIEGO, March 14, 2023 (GLOBE NEWSWIRE) -- Adamis Pharmaceuticals Corporation (NASDAQ: ADMP), a commercial-stage biopharmaceutical company primarily focused on developing and commercializing products in various therapeutic areas, including opioid overdose, allergy, respiratory and inflammatory...

NEW YORK, NY / ACCESSWIRE / March 5, 2023 / Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to: INDUS Realty Trust, Inc. (NASDAQ: IND...

NEW YORK, NY / ACCESSWIRE / March 2, 2023 / Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to: Ranger Oil Corporation (NASDAQ:ROCC)'...

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Source: Wirestock Creators / Shutterstock Clover Health (NASDAQ: CLOV ) stock is on the rise Tuesday thanks to the company’s earnings report for the fourth quarter of 2022. One of the biggest factors that h...

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Source: Tada Images / Shutterstock.com Digital World Acquisition (NASDAQ: DWAC ) stock is on the move Tuesday after the company announced a new deadline for June 8, 2023 . That new deadline is how long the compan...

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Source: shutterstock.com/Champhei It’s an unusual day for Adamis Pharmaceuticals (NASDAQ: ADMP ) stock traders, to say the least. That’s because the company recently announced its intent to acquire DMK ...

Specialty biopharmaceutical company focused on developing and commercializing products in various therapeutic areas, including opioid overdose, allergy, respiratory and inflammatory disease Adamis Pharmaceuticals ( ADMP ) and DMK Pharmaceuticals plan a merger . DMK...

Combined company will have commercial products and a library of development candidates, two of which are clinical stage Will be under the leadership of DMK CEO, Dr. Ebrahim (Eboo) Versi MD, PhD Lead development program will be a clinical stage therapeutic under development for the...